Cullinan Therapeutics, Inc. (CGEM)
21.78
-0.29
(-1.31%)
USD |
NASDAQ |
Sep 01, 16:00
21.78
0.00 (0.00%)
After-Hours: 18:59
Cullinan Therapeutics Total Long Term Debt (Quarterly) : 1.405M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.405M |
| March 31, 2026 | 1.658M |
| December 31, 2025 | 1.903M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.125M |
| March 31, 2025 | 0.493M |
| December 31, 2024 | 0.849M |
| September 30, 2024 | 1.188M |
| June 30, 2024 | 1.519M |
| March 31, 2024 | 1.84M |
| December 31, 2023 | 2.15M |
| September 30, 2023 | 2.446M |
| June 30, 2023 | 2.734M |
| March 31, 2023 | 3.17M |
| Date | Value |
|---|---|
| December 31, 2022 | 3.59M |
| September 30, 2022 | 3.992M |
| June 30, 2022 | 0.596M |
| March 31, 2022 | 0.736M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Rallybio Corp. | 0.00 |
| MapLight Therapeutics, Inc. | 0.755M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |